The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design

The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design

Abstract Comprehensive treatment of Alzheimer's disease (AD) requires not only pharmacologic treatment but also management of existing medical conditions and lifestyle modifications including diet, cognitive training, and exercise. We present the design and methodology for the Coaching for Cogn...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jared C. Roach, Junko Hara, Deborah Fridman, Jennifer C. Lovejoy, Kathleen Jade, Laura Heim, Rachel Romansik, Adrienne Swietlikowski, Sheree Phillips, Molly K. Rapozo, Maria A. Shay, Dan Fischer, Cory Funk, Lauren Dill, Michael Brant‐Zawadzki, Leroy Hood, William R. Shankle
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:	Alzheimer's disease Alzheimer's disease and related disorders cognitive decline cognitive impairment cognitive training dementia
Online Access:	https://doi.org/10.1002/trc2.12318
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The bidirectional relationship between subjective visual function and domain-specific cognition in cognitively unimpaired older adults and adults with mild cognitive impairment
by: Abigail Dubois, et al.
Published: (2024-11-01)

Drinking coffee may reduce chances of developing Alzheimer’s disease: systematic literature review and meta-analysis
by: Sheba R. David, et al.
Published: (2022-10-01)

Mechanisms and functions of the cerebral-cognitive reserve in patients with Alzheimer's disease: a narrative review
by: Alena P. Sidenkova, et al.
Published: (2024-10-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
by: Xiao-jun Jing, et al.
Published: (2024-09-01)

Effectiveness of Repetitive Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Early Alzheimer’s Disease: A Systematic Review and Meta-analysis
by: Palash Kumar Malo, et al.
Published: (2025-01-01)

Recent Advances in Bacopa Monnieri Research: Neuroprotective Effects and Cognitive Decline Mitigation in Neurodegenerative Diseases with a Focus on Alzheimer’s and Parkinson’s Diseases
by: Mateusz Bychowski, et al.
Published: (2024-12-01)

Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management
by: Agnieszka Kosińska, et al.
Published: (2025-02-01)

Linking cognitive and behavioral reserve: Evidence from the CAN‐PROTECT study
by: Dylan X. Guan, et al.
Published: (2024-10-01)

Distinctive Gait Variations and Neuroimaging Correlates in Alzheimer's Disease and Cerebral Small Vessel Disease
by: Xia Zhou, et al.
Published: (2024-12-01)

Can Phonemic Verbal Fluency Be Used to Predict Alzheimer’s Disease?
by: Sara García-González
Published: (2024-11-01)

A systematic review and meta‐analysis of basal microbiota and cognitive function in Alzheimer's disease: A potential target for treatment or a contributor to disease progression?
by: Ana Maria Jimenez‐García, et al.
Published: (2024-10-01)

Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01)

Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer’s disease neuropathologyResearch in context
by: Mathilde Antoniades, et al.
Published: (2024-11-01)

Guidelines for the use and interpretation of Alzheimer’s disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
by: Adalberto Studart Neto, et al.
Published: (2024-11-01)

A systematic review and meta-analysis of the impact of transcranial direct current stimulation on cognitive function in older adults with cognitive impairments: the influence of dosage parameters
by: Thatchaya Prathum, et al.
Published: (2025-02-01)

Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer’s disease
by: Colin Birkenbihl, et al.
Published: (2025-01-01)

Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease
by: Xiang Zou, et al.
Published: (2022-01-01)

Comparative Study of Injected Alzheimer’s Disease Models in Rats: Insights from Experimental Research
by: Hanane Doumar, et al.
Published: (2024-11-01)

The Impact of Edentulism and Periodontitis on Cognition
by: Lauren Berard, et al.
Published: (2024-12-01)

Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach
by: Deepti Putcha, et al.
Published: (2025-02-01)

Expert consensus on diagnostic management specification and biomarker disclosure for subjective cognitive decline
by: Neurodegenerative Disease Special Committee, China Association for Promotion of Health Science and Technology
Published: (2024-11-01)

Prospective associations of interleukin‐6 and APOE allele with cognitive decline in biracial community‐dwelling older adults: The Chicago Health and Aging Project (CHAP)
by: Ted K. S. Ng, et al.
Published: (2024-10-01)

ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes
by: Luciana Mascarenhas Fonseca, et al.
Published: (2024-10-01)

The link between periodontitis and Alzheimer's disease – Brunei context
by: Sarah Nabihah Mohamad Fadzli, et al.
Published: (2024-12-01)

Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum
by: Han Zhao, et al.
Published: (2025-02-01)

Neurogranin in Alzheimer's Disease: Roles in synaptic function, pathology, and potential as a diagnostic biomarker
by: Rajkumar Bavaharini, et al.
Published: (2024-09-01)

Improving cognitive impairment through chronic consumption of natural compounds/extracts: a systematic review and meta-analysis of randomized controlled trials
by: Long Ngo Hoang, et al.
Published: (2025-01-01)

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
by: Dan Chen, et al.
Published: (2025-01-01)

Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01)

Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons
by: Sarah L. Booth, et al.
Published: (2022-01-01)

Amyloid PET ordering practices in a memory disorders clinic
by: Katherine W. Turk, et al.
Published: (2022-01-01)

Impact of amyloid PET in the clinical care of veterans in a tertiary memory disorders clinic
by: Ana Laura Vives‐Rodriguez, et al.
Published: (2022-01-01)

Knockdown of TREML2 Alleviates Neuropathological Hallmarks and Cognitive Deficiency in a Model of Sporadic Alzheimer’s Disease
by: Fu XX, et al.
Published: (2024-12-01)

Impact of Coconut Oil and Its Bioactive Metabolites in Alzheimer’s Disease and Dementia: A Systematic Review and Meta-Analysis
by: Duaa Bafail, et al.
Published: (2024-11-01)

Role of visual function and performance of activities of daily living in cognitive function in patients with mild cognitive impairment: a cross-sectional study
by: Chunhui Zhou, et al.
Published: (2025-02-01)

Periodontal Indices as Predictors of Cognitive Decline: Insights from the PerioMind Colombia Cohort
by: Catalina Arévalo-Caro, et al.
Published: (2025-01-01)

Tangeretin offers neuroprotection against colchicine-induced memory impairment in Wistar rats by modulating the antioxidant milieu, inflammatory mediators and oxidative stress in the brain tissue
by: Olalekan Bukunmi Ogunro, et al.
Published: (2025-02-01)

Prospective observational study to evaluate the feasibility of the mobile app for mild cognitive impairment detection and screening
by: Reo Hamaguchi, et al.
Published: (2025-02-01)

Dynamic changes and prognostic value of glutathione S-transferase alpha in mild cognitive impairment and Alzheimer’s disease
by: Yangyang Tang, et al.
Published: (2024-12-01)

Feasibility and acceptability of a videoconference-based cognitive-behavioral intervention for caregivers of individuals living with mild cognitive impairment or early Alzheimer's disease
by: Phylicia Verreault, et al.
Published: (2024-12-01)